Earnings Call · Q2 FY2021·2021-08-03

Q2 21EPS +9.73%·Rev n/aQ1 21EPS -28.68%·Rev n/aQ4 20EPS -3.46%·Rev n/aQ3 20EPS +14.01%·Rev n/a⚠ consensus missing

Esperion Therapeutics, Inc. ESPR

Ben Church — Head of Investor Relations and Corporate Communications

Sheldon Koenig — Chief Executive Officer

Joanne Foody — Chief Medical Officer

Rick Bartram — Chief Financial Officer

−4.8%1d on move date−5.6% vs SPY3d+0.1%5d−6.4%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ESPR calls or request research access.

More ESPR calls Browse calls Request research access